Cargando…

Rapid antigen testing and non-infectious shedding of SARS-Cov2

Detalles Bibliográficos
Autores principales:	Weiss, Günter, Bellmann-Weiler, Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775831/ https://www.ncbi.nlm.nih.gov/pubmed/33386584 http://dx.doi.org/10.1007/s15010-020-01570-w

Ejemplares similares

Antigen testing and non-infectious shedding of SARS-COV-2
por: Raveh, Yehuda, et al.
Publicado: (2021)

Evaluating the clinical utility and sensitivity of SARS-CoV-2 antigen testing in relation to RT-PCR Ct values
por: Lanser, Lukas, et al.
Publicado: (2020)

SARS-CoV-2 rapid antigen detection tests
por: Weitzel, Thomas, et al.
Publicado: (2021)

SARS-CoV-2 rapid antigen detection tests
por: Fouzas, Sotirios
Publicado: (2021)

Comparative evaluation of four SARS-CoV-2 antigen tests in hospitalized patients
por: Thommes, Lis, et al.
Publicado: (2021)

SARS-CoV-2 rapid antigen detection tests – Authors' reply
por: Peeling, Rosanna W, et al.
Publicado: (2021)

SARS-CoV-2 antigen-detecting rapid tests for the delta variant
por: Bekliz, Meriem, et al.
Publicado: (2022)

SARS-CoV-2 shedding and infectivity
por: Atkinson, Barry, et al.
Publicado: (2020)

Setting-specific variability of false-positive result rates with rapid testing for SARS-CoV-2 antigen
por: Posteraro, Patrizia, et al.
Publicado: (2022)

Testing for responses to the wrong SARS-CoV-2 antigen?
por: Rosadas, Carolina, et al.
Publicado: (2020)

Viable virus shedding during SARS-CoV-2 reinfection
por: Letizia, Andrew G, et al.
Publicado: (2021)

Comparative evaluation of four rapid SARS-CoV-2 antigen detection tests using universal transport medium
por: Weitzel, Thomas, et al.
Publicado: (2021)

Fecal Shedding of SARS CoV-2: Implications for Disease Spread and Quarantine
por: Meena, Jitendra, et al.
Publicado: (2020)

Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
por: Aydillo, Teresa, et al.
Publicado: (2020)

Real world clinical performance of SARS-CoV-2 rapid antigen tests in suspected COVID-19 cases in Taiwan
por: Tsai, Shao-Chen, et al.
Publicado: (2021)

Maintaining genomic surveillance using whole-genome sequencing of SARS-CoV-2 from rapid antigen test devices
por: Martin, Genevieve E, et al.
Publicado: (2022)

Performance evaluation of Roche and Abbott Panbio multiplex SARS-CoV-2 and influenza A/B rapid antigen tests
por: Batty, Mitchell, et al.
Publicado: (2023)

SARS-CoV-2 rapid diagnostic tests for emerging variants
por: Bekliz, Meriem, et al.
Publicado: (2021)

Prolonged Live SARS-CoV-2 Shedding in a Maintenance Dialysis Patient
por: Lacson, Eduardo, et al.
Publicado: (2020)

Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection
por: Boucau, Julie, et al.
Publicado: (2022)

Persistent Viral Shedding after SARS-CoV-2 Infection in an Infant with Severe Combined Immunodeficiency
por: Hariharan, Sankar Vaikom, et al.
Publicado: (2021)

Rectally shed SARS-CoV-2 lacks infectivity: time to rethink faecal–oral transmission?
por: Pedersen, Rune M., et al.
Publicado: (2021)

SARS-CoV-2 rapid antigen test: High sensitivity to detect infectious virus
por: Nordgren, Johan, et al.
Publicado: (2021)

Shedding of infectious SARS-CoV-2 despite vaccination
por: Riemersma, Kasen K., et al.
Publicado: (2022)

Reply to: Rectally shed SARS-CoV-2 lacks infectivity: time to rethink faecal–oral transmission?
por: Guo, Meng, et al.
Publicado: (2021)

Rapid tests for quantification of infectiousness are urgently required in patients with COVID-19
por: Pan, Daniel, et al.
Publicado: (2021)

Rapid antigen tests for SARS-CoV-2
por: Liu, Michael, et al.
Publicado: (2021)

Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
por: Zheng, Ming, et al.
Publicado: (2020)

Rapid identification and tracking of SARS-CoV-2 variants of concern
por: Chakraborty, Debojyoti, et al.
Publicado: (2021)

Intestinal Shedding of SARS-CoV-2 in Children: No Evidence for Infectious Potential
por: Nogueira, Filomena, et al.
Publicado: (2022)

Ct values and infectivity of SARS-CoV-2 on surfaces
por: Kampf, Günter, et al.
Publicado: (2021)

Need for a high-specificity test for confirming weakly positive result in an immunochromatographic SARS-CoV-2-specific antigen test: A case report
por: Tanimoto, Takuya, et al.
Publicado: (2021)

Antigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6
por: Dijokaite-Guraliuc, Aiste, et al.
Publicado: (2022)

Evaluation of a Rapid Antigen Test To Detect SARS-CoV-2 Infection and Identify Potentially Infectious Individuals
por: Korenkov, Michael, et al.
Publicado: (2021)

Challenges and issues of SARS-CoV-2 pool testing
por: Lee, Jaehyeon, et al.
Publicado: (2020)

Challenges and issues of SARS-CoV-2 pool testing
por: Mishra, Baijayantimala, et al.
Publicado: (2020)

Challenges and issues of SARS-CoV-2 pool testing
por: Eberhardt, Jens N, et al.
Publicado: (2020)

Single-Center Experience in Detecting Influenza Virus, RSV and SARS-CoV-2 at the Emergency Department
por: Nairz, Manfred, et al.
Publicado: (2023)

ColdZyme® protects airway epithelia from infection with BA.4/5
por: Viktoria, Zaderer, et al.
Publicado: (2022)

BNT162b2 antigen dose and SARS-CoV-2 omicron infection in adolescents
por: Chemaitelly, Hiam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5gsisrrtdrijlqpd6gvf5e6eu1